Chattanooga Medical Research LLC. | Chattanooga, TN

Research site

(Unclaimed)

Location

2341 Mccallie Avenue, Suite 300, Chattanooga, Tennessee, United States of America

Site insights

Top conditions

Top treatments

Elagolix

Mesafem

Estradiol

Progesterone

Linzagolix

SCY-078

Lorundrostat

Gefapixant

Pregabalin

OG-6219

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

11 of 59 total trials

A First-in-human Safety Trial of BNT331 Administered as Single Ascending Doses in Healthy Women and as Multiple Ascending Doses in Women Diagnosed With Bacterial Vaginosis

This is a two-part, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and ef...

Active, not recruiting

Bacterial Vaginosis

Drug: BNT331

Other: Placebo

A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)

This study compares semaglutide, together with a lower dose of insulin glargine, to a higher dose of insulin glargine in participants with type 2 dia...

Active, not recruiting

Obesity

Diabetes Mellitus, Type 2

Drug: Insuline glargine U100 (titrated)

Drug: Insuline glargine U100 (reduced)

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

This study will evaluate the efficacy and safety of Armour Thyroid treatment compared with synthetic T4 in subjects who have primary hypothyroidism a...

Enrolling

Hypothyroidism

Drug: Levothyroxine

Drug: Armour Thyroid

A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain (ELENA)

The purpose of this global Phase 2 study is to determine the efficacy, safety, and tolerability of 3 dose levels of OG-6219 in pre-menopausal women b...

Active, not recruiting

Endometriosis

Drug: Placebo

Drug: OG-6219

A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss and Fat Loss (COURAGE)

This study is researching experimental drugs called trevogrumab and garetosmab (called "study drugs") in combination with another drug, semaglutide (...

Active, not recruiting

Obesity

Drug: Matching Placebo-Trevogrumab

Drug: Matching Placebo-Garetosmab

Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females

This study will be in two parts, Part A and Part B. The primary objective of Part A is to evaluate the contraceptive efficacy of LPRI-CF113. The seco...

Active, not recruiting

Contraception

Change in Bone Mineral Density

Drug: Drospirenone

Evaluation of Efficacy, Safety and Tolerability of VeraCept IUD

To assess the contraceptive efficacy (prevention of pregnancy) of VeraCept

Active, not recruiting

Women at Risk for Pregnancy

Drug: VeraCept

FemBloc® Permanent Contraception - Early Pivotal Trial (BLOC)

Prospective, multi-center, international, non-randomized, two-arm study of subjects undergoing either FemBloc or laparoscopic bilateral tubal sterili...

Active, not recruiting

Contraception

Device: FemBloc

Procedure: Laparoscopic bilateral tubal sterilization

Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects with Hypertension

This study is to evaluate the long-term safety, efficacy and tolerability of lorundrostat (an aldosterone synthase inhibitor) in subjects with hypert...

Invitation-only

Hypertension

Drug: lorundrostat

Drug: Placebo

Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine (ATO-BOTOX)

Migraine is characterized by attacks of throbbing, moderate or severe headache, often associated with nausea, vomiting, and/or sensitivity to light a...

Active, not recruiting

Chronic Migraine

Drug: Atogepant

Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain (ELARIS EM-COC)

Endometriosis is a painful disorder of the uterus affecting 6-10% of women of childbearing age. Endometriosis affects daily activities, social relati...

Enrolling

Endometriosis

Drug: Elagolix

Drug: Placebo